On Feb. 28, 2020, commentary appeared in The New England Journal of Medicine that discussed the emergence and…
On Feb. 27, 2020, a consortium of philanthropic, non-profit and private sector organisations launched a collaboration that aims…
On Feb. 27, 2020, Innovation Pharma announced the Company had signed a Material Transfer Agreement (MTA) with one…
On Feb. 25, 2020, the U. S. National Institutes of Health (NIH) announced it had launched a $1…
On Feb. 26, 2020, Georgia Institute of Technology and Shriners Hospitals for Children announced a collaborative research affiliation…
On Feb. 25, 2020, the National Institutes of Health (NIH) announced that a randomized, controlled clinical trial to…
On Feb. 25, 2020, a University of British Columbia researcher was part of an international team working with…
On Feb. 25, 2020, Vir Biotech announced a development and manufacturing collaboration to advance and produce human monoclonal…
On Feb. 24, 2020, researchers at National Institute of Allergy and Infectious Disease’s Rocky Mountain Laboratories in Hamilton,…
On Feb. 21, 2020, Lundbeck announced that VYEPTI™ (eptinezumab-jjmr) had been approved by the U.S. Food and Drug…
On Feb. 21, 2020, the U.S. Food and Drug Administration (FDA) approved NEXLETOL (bempedoic acid) tablet, an oral,…
On Feb. 21, 2020, a $2 million gift from University of Missouri alumni will support the university’s NextGen…
On Feb. 21, 2020, the U.S. Food and Drug Administration (FDA) authorized marketing of the first test to…
On Feb. 24, 2020, researchers reported that the spikes crowning the new coronavirus that causes COVID-19 atypical pneumonia…
On Feb. 20, 2020, using a machine-learning algorithm, researchers at MIT and the Broad Institute of MIT and…
On Feb. 20, 2020, Tim Boyle, CEO of Columbia Sportswear, and his wife, Mary, made a $10 million…
On Feb. 19, 2020, Cancer Prevention & Research Institute of Texas (CPRIT) announced it had awarded 55 grants…
On Feb. 13, 2020, a study published in Cell provided an unprecedented look at the dozens of molecular…
On Feb. 13, 2020, National Institutes of Health (NIH) scientists announced that the experimental antiviral remdesivir successfully prevented…
On Feb. 12, 2020, Vir Biotech announced it had identified two monoclonal antibodies (mAbs) that bind to SARS-CoV-2…
On Feb. 5, 2020, The Pan-cancer analysis of whole genomes was published in Nature. The flagship paper of…
On Feb. 5, 2020, to fight further spread of the new coronavirus (2019-nCoV) outbreak in China and globally,…
On Feb. 5, 2020, an international team announced that it had completed the most comprehensive study of whole…
On Feb. 4, 2020, BioMotiv and Bristol-Myers Squibb announced the launch of Anteros Pharmaceuticals, a biotechnology company focused…
On Feb. 4, 2020, the Fred Hutchinson Cancer Research Center announced that a promising HIV vaccine trial was…
On Jan. 31, 2020, Vaxart announced it had initiated a program to develop a coronavirus vaccine candidate based…
On Jan 31, 2020, Taconic Biosciences announced that it had expanded its immuno-oncology portfolio with the launch of…
On Jan. 30, 2020, the University of Washington (UW) announced that a new center was being created with…
On Jan. 29, 2020, 23andMe announced an agreement with Almirall to in-license 23andMe’s bispecific monoclonal antibody designed to…
On Jan. 29, 2020, Sorrento Therapeutics announced it had initiated a clinical and manufacturing collaboration with Celularity, a…